Patent details

EP1267857 Title: In vitro use of astaxanthin for pretreatment of cells prior to UV-exposure to inhibit the activation of NF-kB

Basic Information

Publication number:
EP1267857
PCT Application Number:
PCT/SE/2001/000600
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019160225
PCT Publication Number:
WO/2001/072296
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
In vitro use of astaxanthin for pretreatment of cells prior to UV-exposure to inhibit the activation of NF-kB
French Title of Invention:
Utilisation in vitro d'astaxanthine pour le pretraitement de cellules avant exposition aux rayons UV afin d'inhiber l'activation de NF-KB
German Title of Invention:
In-vitro-Verwendung von Astaxanthin zur Vorbehandlung von Zellen vor UV-Bestrahlung zwecks Hemmung der Aktivierung von NF-KB
SPC Number:

Dates

Filing date:
21/03/2001
Grant date:
14/02/2007
EP Publication Date:
14/02/2007
PCT Publication Date:
04/10/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/01/2003
EP B1 Publication Date:
14/02/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/03/2007
Expiration date:
21/03/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/03/2001
 
 

Name:
ASTACAROTENE AB
Address:
Idrottsvägen 4, 134 40 Gustavsberg, Sweden (SE)

Inventor

1

Name:
ANDERSSON Tove
Address:
Sweden (SE)

2

Name:
PETTERSSON Sven
Address:
Sweden (SE)

Priority

Priority Number:
0001071
Priority Date:
27/03/2000
Priority Country:
Sweden (SE)

Classification

Main IPC Class:
A61K 31/12;
Filing date Document type Number of pages